Primus In News
How to ensure sustainability and wider stakeholder acceptability in NLEM revisions
07-12-2022
Nilaya Varma, CEO and Managing Director, Primus Partners shares his thoughts on the 4th revision of the National List of Essential Medicines, in particular releasing frequent revisions to the list as well as providing greater financial incentives to pharma companies.
Explore Related Insights
- Skill Universities: A Sustainable Solution to Bridging the Gap Between Education and Employment in the Modern Workforce
- Moving the Needle | August 2023
- Climate justice for all, by all: Multi-sectoral framework for optimal public health outcomes
- Mission Karmayogi National Programme for Civil Services Capacity Building
